You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1194 Mechanism of action of ivonescimab (AK112/SMT112): a first-in-class tetravalent Fc-silent bispecific antibody with dual blockade of PD-1 and VEGF that promotes cooperative biological effects

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immuno-Conjugates and Chimeric Molecules
1194 Mechanism of action of ivonescimab (AK112/SMT112): a first-in-class tetravalent Fc-silent bispecific antibody with dual blockade of PD-1 and VEGF that promotes cooperative biological effects

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023336055
Dec 2023114024
Jan 202493024
Feb 2024100013
Mar 2024128035
Apr 202412203
May 2024188044
Jun 2024354060
Jul 2024364048
Aug 2024324057
Sep 202419700226
Oct 20248330236
Nov 20248900199
Dec 20246260134
Jan 20258500148
Feb 20252620241
Mar 202560190
Apr 202500111
May 202500110
Jun 20250082
Total756002040